Aegerion Pharmaceuticals

• NCT02765841

  Phase 3, Withdrawn, 0 people, 9 May 2016

• NCT02173158

  Phase 3, Completed, 9 people, 24 Jun 2014

• NCT02080468

  Phase 1, Completed, 32 people, 6 Mar 2014

• NCT02080455

  Phase 1, Completed, 32 people, 6 Mar 2014

• NCT02044419

  Phase 1, Completed, 32 people, 24 Jan 2014

• NCT01915771

  Phase 1, Completed, 15 people, 5 Aug 2013

• NCT01760187

  Phase 1, Completed, 72 people, 4 Jan 2013

• NCT01556906

  Phase 2, Completed, 6 people, 19 Mar 2012

• NCT00943306

  Phase 3, Completed, 19 people, 22 Jul 2009

• NCT00730236

  Phase 3, Completed, 29 people, 8 Aug 2008

• NCT00690443

  Phase 2, Completed, 44 people, 4 Jun 2008

• NCT00559962

  Phase 2, Completed, 260 people, 19 Nov 2007

• NCT00474240

  Phase 2, Completed, 157 people, 16 May 2007

• NCT00405067

  Phase 2, Completed, 60 people, 29 Nov 2006

• NCT00359281

  Phase 2, Completed, 125 people, 2 Aug 2006

• Predictors of aortic stenosis in homozygous familial hypercholesterolemia: A study from the Canadian HoFH registry

  Consulting or advice, Fees or honoraria, 2 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov